Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

VGM & ASSOCIATESHealthcare MSO LEARN ABOUT VGM

The House of Representatives Passed the Lymphedema Treatment Act!

Published in Government Relations on November 17, 2022

This article was recently featured on LymphedemaTreatmentAct.org

Today, the full House of Representatives passed the Lymphedema Treatment Act, moving us one giant step closer to the bill becoming law!

The vote was 402/13 - a tremendous show of bipartisan support! We will share a video as soon as it becomes available.

Now, we need to keep the momentum going - we have just one month to get the bill through the Senate! The last in-session day for this Congress is currently scheduled for December 16th. If the bill is not signed into law by the end of this Congress, then we have to begin the process all over again next January.

Please take a moment to thank House members and urge the Senate to follow suit and act swiftly to pass the LTA! Click here to send your email to the House and Senate in one step. And stay tuned for more action items in the new future.

We truly wouldn't be here without you. I know sometimes we all wonder if our voice makes a difference, but I can assure you it does. And you don't have to take my word for it. Just watch the video footage from the Committee Markup in July and the Floor Statements on Monday. Members of Congress repeatedly commented on how much hearing from advocates made a difference in bringing this issue to the forefront.

Your voice is making change happen!!

TAGS

From Our Experts

August Of Action: Your Chance To Connect With Congress thumbnail

August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you.

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail

Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications.

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail

HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry.

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk.

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review.

Evaluating the Value of a Payer Contract thumbnail

Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.

Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

Give your business an advantage over the competition.

Become a Member